Arcutis BiotherapeuticsARQT
那斯達克 · USD
14.58
0.00
(0.00%)
收盤 08/01 03:59 (UTC+8)
盤後
14.58
14.58
(0.00%)
08/01 03:59 (UTC+8)
Arcutis BiotherapeuticsARQT
14.58
0.00
(0.00%)
財務數據
損益表
- 0.03
- 0.03
- 0.05
- 0.38
- 0.14
- 0.50
- 0.31
- 0.45
- 0.71
- 0.66
- 308.41
- -6.08
- 86.62
- 634.28
- -64.51
- 266.47
- -37.75
- 45.04
- 59.45
- -7.73
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 65,846 | 71,360 | 44,755 | 30,858 | 49,569 | 13,526 | 38,109 | 5,190 | 2,781 | 2,961 |
營業成本 | 8,830 | 6,905 | 5,503 | 3,464 | 3,256 | 2,246 | 1,182 | 776 | 783 | 485 |
營業毛利 | 57,016 | 64,455 | 39,252 | 27,394 | 46,313 | 11,280 | 36,927 | 4,414 | 1,998 | 2,476 |
營業費用 | 81,545 | 72,087 | 78,318 | 77,471 | 77,935 | 72,449 | 73,831 | 71,177 | 78,263 | 70,900 |
研發費用 | 17,543 | 14,480 | 19,501 | 19,298 | 23,141 | 23,775 | 26,236 | 25,219 | 35,345 | 33,877 |
推銷及管理費用 | 64,002 | 57,607 | 58,817 | 58,173 | 54,794 | 48,674 | 47,595 | 45,958 | 42,918 | 37,023 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -24,529 | -7,632 | -39,066 | -50,077 | -31,622 | -61,169 | -36,904 | -66,763 | -76,265 | -68,424 |
其他收入及費用 | 2,730 | 2,718 | 4,182 | 5,229 | 4,044 | 2,672 | 2,786 | 3,121 | 3,207 | 3,320 |
利息費用 | 2,982 | 5,551 | 6,653 | 7,484 | 7,480 | 7,762 | 7,559 | 7,349 | 7,042 | 6,915 |
稅前純益 | -24,781 | -10,465 | -41,537 | -52,332 | -35,058 | -66,259 | -41,677 | -70,991 | -80,100 | -72,019 |
所得稅 | 279 | 323 | - | - | 324 | 25 | 3,088 | - | - | - |
稅後純益 | -25,060 | -10,788 | -41,537 | -52,332 | -35,382 | -66,284 | -44,765 | -70,991 | -80,100 | -72,019 |
基本每股稅後盈餘(元) | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 | -1.31 | -1.18 |
稀釋每股稅後盈餘(元) | -0.20 | -0.08 | -0.33 | -0.43 | -0.32 | -0.59 | -0.73 | -1.15 | -1.31 | -1.14 |
基本平均股數(千股) | 126036.00 | 124918.00 | 124302.00 | 123480.00 | 111048.00 | 92580.00 | 61727.00 | 61430.00 | 61169.00 | 60959.00 |
稀釋平均股數(千股) | 126036.00 | 124918.00 | 124302.00 | 123480.00 | 111048.00 | 92580.00 | 61727.00 | 61430.00 | 61169.00 | 60959.00 |
還原基本每股稅後盈餘(元) | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 | -1.31 | -1.18 |
還原稀釋每股稅後盈餘(元) | -0.20 | -0.08 | -0.33 | -0.43 | -0.32 | -0.59 | -0.73 | -1.15 | -1.31 | -1.14 |
還原基本平均股數(千股) | 126,036 | 124,918 | 124,302 | 123,480 | 111,048 | 92,580 | 61,727 | 61,430 | 61,169 | 60,959 |
還原稀釋平均股數(千股) | 126,036 | 124,918 | 124,302 | 123,480 | 111,048 | 92,580 | 61,727 | 61,430 | 61,169 | 60,959 |
EBITDA(千元) | -19,526 | -5,552 | -35,144 | -46,885 | -28,945 | -59,584 | -35,263 | -65,080 | -74,856 | -67,099 |